Baseline | Immediately after Ex | Post-Ex 30 min | Post-Ex 60 min | p value | |||
---|---|---|---|---|---|---|---|
Interaction | Trial | Time | |||||
Adrenaline (pg/ml) | |||||||
SE trial | 23.3 ± 9.8 | 37.8 ± 15.3b | 22.2 ± 9.5 | 19.6 ± 9.3 | 0.075 | 0.109 | < 0.001 |
LE trial | 25.8 ± 10.8 | 50.7 ± 17.9b | 23.6 ± 8.3 | 21.9 ± 6.3 | |||
Noradrenaline (pg/ml) | |||||||
SE trial | 243.3 ± 85.0 | 357.4 ± 91.7b | 166.8 ± 39.7 | 176.3 ± 59.1 | 0.124 | 0.352 | < 0.001 |
LE trial | 252.5 ± 79.8 | 408.3 ± 100.4b | 186.9 ± 90.8 | 169.1 ± 65.0 | |||
Cortisol (µg/dl) | |||||||
SE trial | 14.2 ± 2.8 | 9.8 ± 2.0b | 8.8 ± 2.3b | 8.1 ± 2.7b | 0.971 | 0.459 | < 0.001 |
LE trial | 13.7 ± 2.9 | 9.5 ± 3.3b | 8.7 ± 3.5b | 7.6 ± 2.7b | |||
Insulin (µU/ml) | |||||||
SE trial | 5.8 ± 2.1a | 3.7 ± 1.1a, b | 4.1 ± 1.5a | 3.8 ± 1.4 | 0.359 | 0.018 | < 0.001 |
LE trial | 4.6 ± 1.2 | 2.8 ± 1.0b | 3.2 ± 1.2 | 3.3 ± 1.1 |